Skip to main content
Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
395.20
+5.50 (1.41%)
Mar 10, 2026, 11:40 AM IST

Biocon Revenue

Biocon had revenue of 41.73B INR in the quarter ending December 31, 2025, with 9.20% growth. This brings the company's revenue in the last twelve months to 168.27B, up 13.99% year-over-year. In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B with 3.43% growth.

Revenue (ttm)
168.27B
Revenue Growth
+13.99%
P/S Ratio
3.75
Revenue / Employee
10.25M
Employees
16,420
Market Cap
630.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025152.62B5.06B3.43%
Mar 31, 2024147.56B35.82B32.05%
Mar 31, 2023111.74B29.90B36.54%
Mar 31, 202281.84B10.41B14.57%
Mar 31, 202171.43B8.43B13.37%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Anthem Biosciences 20.02B
OneSource Specialty Pharma 14.19B
Concord Biotech 11.59B
Blue Jet Healthcare 10.53B
Supriya Lifescience 7.35B
Zota Health Care 4.73B
Dishman Carbogen Amcis 27.97B
Panacea Biotec 6.06B
Revenue Rankings

Biocon News

More News